Match each patient's clinical profile with the most appropriate contraceptive method based on the Medical Eligibility Criteria for Contraceptive Use.
- A 34-year-old woman with active breast cancer who desires a highly effective, long-acting reversible contraceptive method.Copper intrauterine device
- A 26-year-old woman with Wilson disease and a bicornuate uterus who desires a highly effective, long-acting reversible contraceptive method.Subdermal etonogestrel implant
- A 29-year-old woman with a history of unprovoked deep vein thrombosis and heavy menstrual bleeding causing symptomatic anemia.Levonorgestrel-releasing intrauterine device
- A 23-year-old woman with sickle cell disease who desires a highly effective contraceptive method that may also decrease the frequency of her vaso-occlusive pain crises.Depot medroxyprogesterone acetate
Cevap
The correct matches depend on identifying absolute contraindications and secondary benefits. Active breast cancer requires the hormone-free copper intrauterine device. Wilson disease and a bicornuate uterus necessitate the subdermal etonogestrel implant to avoid copper toxicity and uterine placement. Deep vein thrombosis with heavy bleeding is best managed with the levonorgestrel-releasing intrauterine device. Sickle cell disease benefits uniquely from depot medroxyprogesterone acetate.
Each correct pairing navigates the Medical Eligibility Criteria by avoiding Category 4 conditions (e.g., placing hormones in breast cancer patients, placing any device in a distorted uterine cavity) while maximizing secondary benefits (e.g., treating heavy bleeding with a levonorgestrel device, preventing pain crises with depot injections).
Adım Adım Çözüm
Anahtar Kavram
Applying the Medical Eligibility Criteria for contraceptive use to navigate complex absolute contraindications (Category 4) and utilize non-contraceptive benefits.
Tahmini Süre:1m 30s